In earlier reports, it was shown that mice and monkeys could be immunized against otherwise lethal challenge doses of Coccidioides immitis arthrospores. The vaccine was composed of Formalin-killed, in vitro grown, endosporulating spherules of C. immitis strain Silveira. In this study, mice were immunized as in the earlier work and then challenged intranasally with arthrospores from seven heterologous strains of C. iinmitis. Two of these strains were typical of the species, and five were atypical with respect to their cultural characteristics and morphology of microscopic structures. The vaccinated animals were well protected against challenge doses that were lethal to a majority of the control animals, regardless of the strain of fungus employed. The infection ratios among surviving vaccinated and control animals were comparable, but demonstrable lesions were generally smaller and less numerous in the vaccinated groups. It is suggested that these strains are at least immunogenically similar, although not necessarily identical, and that a vaccine prepared from a single strain of C. immitis would be practical for an immunization program.
In a series of papers, Levine and his associates (5 to 8) have reported that mice and monkeys could be immunized against otherwise lethal challenge doses of Coccidioides immitis arthrospores. The vaccine was prepared from Formalinkilled endosporulating spherules which had been grown in vitro according to a modification (5) of the original method of Converse (1) . Mice were challenged via the intranasal route with suspensions of arthrospores harvested from cultures of the Silveira strain of C. immitis. The LD5o dose for nonvaccinated mice was generally of the order of 50 viable particles, whereas the LD5o dose for the vaccinated animals has ranged up to 100 times greater (7) .
Since an old laboratory stock culture of C. immitis (Silveira strain) had been used in the manufacture of the vaccine and also for the challenge dose of spores, Levine et The animals received three doses of vaccine intramuscularly, each containing 0.7 mg of spherules in a volume of 0.1 ml, at weekly intervals. The thigh muscle sites of both rear limbs were alternated for this purpose. After the third dose, the mice received no further treatment until different groups were challenged, 6 to 8 months later.
Suspensions of cells from seven strains of C. immitis were used to challenge the experimental animals. Two of these strains were typical and five were atypical by cultural characteristics and morphology of microscopic structures. Suspensions of viable particles were harvested into sterile saline from cultures grown for 2 months at room temperature on agar containing glucose (1%) and yeast extract (0.5%) as described by Friedman et al. (2) . Total numbers were determined microscopically with a Neubauer rule counting chamber. These suspensions were composed primarily of single arthrospores, but there were occasional small clumps of hyphae and short strands containing several arthrospores. These were counted as one particle, and the total count was recorded as number of visible particles rather than number of cells. Dilutions of the original suspension were made to yield approximately 2 X 104 particles/ml so that the measured challenge dose volume of 0.05 ml would contain approximately 1,000 particles. Appropriate dilutions were plated on Sabouraud dextrose agar to ascertain the viable numbers in the challenge dose. These are presented in Table 1 . Although the infecting dose is recorded as the number of viable particles, not all of The control and vaccinated animals were separated at random into groups of 19 to 20 mice, and a control group and a vaccinated group were paired for challenge with each strain of C. immitis. The challenge dose was administered intranasally in a volume of 0.05 ml after the mice had been anesthetized by gas generated from a mixture of ethyl alcohol, chloroform, and ether (6) . A few mice died during, or shortly after, anesthesia and instillation of the suspension, and these have not been included in the final results.
The experiment was terminated 5 weeks after challenge since Levine and his associates had demonstrated under similar experimental conditions that later deaths attributable to coccidioidomycosis were infrequent and did not affect the overall interpretation (5). Survivors at 5 weeks were sacrificed, and microscopic and cultural studies were performed on spleen, liver, and lung for demonstration of C. immitis. When there were large numbers of survivors within one group, only a sample was selected at random for complete necropsy studies.
RESULTS
The influence of vaccination on survival in groups of mice challenged with the seven strains of C. immitis are presented in Table 2 . The vaccinated animals were well protected against challenge doses that were lethal to a majority of the control animals, regardless of the strain of fungus employed. At 5 weeks postinfection, the infection ratios between vaccinated and nonvaccinated survivors were comparable, as also noted by Levine et al. (5, 6) , by use of strain Silveira challenge. Among the vaccinated survivors, however, it was quite difficult to find lesions in many of the animals, for these lesions were small and few in 
DISCUSSION
This study and that reported earlier (7) provide evidence that immunogens are shared in common by nine strains of C. immitis, despite the most marked differences in their macroscopic and microscopic characteristics as well as in their history and virulence. The vaccinating strain Silveira, highly virulent for mice, had been maintained on agar medium since its isolation in 1951 from a patient with severe but nonfatal respiratory coccidioidomycosis with erythema nodosum. The strains against which it afforded protection included: (i) strain 46 (7), low in virulence for the mouse but isolated in 1931 from a fatal meningeal case in man; (ii) strain Woodville A-6 (7), isolated recently from soil, highly virulent for mice and implicated in an epidemic among children; and (iii) the isolates reported herein which differ so markedly from typical C. immitis strains by cultural and morphological criteria (3 Nevertheless, the finding that marked cultural and morphological diversity (3) occurs within the monospecific genus Coccidioides presents certain problems. Immunological similarity does not imply immunological identity, nor does it follow necessarily that immunological similarity will be a feature in yet other atypical strains of this fungus. Even though the coccidioidins which have been used are prepared from multiple typical strains of C. immitis, it seems germane to suggest that coccidioidins from atypical cultures should be included in epidemiological surveys and also in serological tests on patients with suspected but not proven disease. The possibility of immunological strain variations among these cultures is being investigated.
The results of the present study would be more complete if it had been possible to immunize animals with vaccine from each of the several strains of C. immitis and then to challenge each group with suspensions from the heterologous strains. Up to now, the most effective immunogenic agent against coccidioidomycosis has been the killed spherule stage of the fungus. Although it has been possible to induce spherule formation under in vitro conditions for a few strains, there are still many isolates of C. immitis which do not convert readily outside of the animal host from a mycelial type of growth to endosporulating spherules. This is being attempted at the present time with the cultures used in this report.
